FIELD: medicine, pharmaceutics.
SUBSTANCE: implant represents a medicated polymer device, e.g. in the form of a rod, designed for release control of a biologically active substance clonidine and derivatives thereof, such as clonidine HCl, for a long period of time, e.g. for 2 months, 3 months, 4 months and even 4.5 months. The above polymer preferentially represents a biodegradable polymer, such as poly(lactide-co-glycolide) or poly(lactic acid). A challenge of using medicated salt forms HCl, such as clonidine consists in release control of the high water-soluble medication up to 4.5 months. It has been found that a particle size distribution control in the medicated powder can provide more uniform medication distribution in a polymer carrier which can be regulated. This enables avoiding formation of aggregates causing faster medication release.
EFFECT: invention refers to medical devices able to release the biologically active substances.
5 cl, 10 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS CONTAINING CLONIDINE IN DEGRADABLE POLYMER | 2009 |
|
RU2494731C2 |
METHODS AND COMPOSITIONS CONTAINING CLONIDINE, APPLICABLE FOR TREATING POSTOPERATIVE PAIN | 2009 |
|
RU2510263C2 |
PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE | 2017 |
|
RU2756514C1 |
DELAYED RELEASE PREPARATIONS CONTAINING VERY LOW MOLECULAR WEIGHT POLYMERS | 2007 |
|
RU2453329C2 |
IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS FOR USING THEM | 2016 |
|
RU2739033C2 |
DOSED FORMS OF ANESTHETICS FOR ANESTHESIA WITH LONG LIBERATION | 2003 |
|
RU2332985C2 |
COMPOSITIONS AND METHODS FOR LONG-TERM RELEASE OF ANTAGONISTS OF GONADOTROPIN-RELEASING HORMONE (GnRH) | 2018 |
|
RU2789057C2 |
MICROCHIP FOR DRUG DELIVERY AND METHODS FOR USE THEREOF | 2014 |
|
RU2711567C2 |
NOVEL DEPOT-PREPARATIONS FOR INJECTION | 2003 |
|
RU2310450C2 |
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
Authors
Dates
2014-06-27—Published
2009-04-17—Filed